Isbn: 9783031386046 - practical management of thyroid cancer: a multidisciplinary approach (9 resultados)

ISBN
Refinar con la Búsqueda avanzada

Filtrar la búsqueda

  • Libros (9)

  • Nuevo (9)

a

Intervalo de precios personalizado (EUR)

a

    • Idioma: Inglés

      Editorial: Springer, 2024

      3031386043 / 9783031386046

      • Tapa dura

      Librería: Books Puddle, New York, NY, Estados Unidos de AmericaBooks Puddle

      Vendedor de 4 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 248,71

      Envío por EUR 3,48 
      Se envía dentro de Estados Unidos de America

      Cantidad disponible: 4 disponibles

      Condición: New.

    • Idioma: Inglés

      Editorial: Springer, 2024

      3031386043 / 9783031386046

      • Tapa dura

      Librería: AHA-BUCH GmbH, Einbeck, AlemaniaAHA-BUCH GmbH

      Vendedor de 5 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 255,87

      Envío por EUR 37,99 
      Se envía de Alemania a Estados Unidos de America

      Cantidad disponible: 1 disponibles

      Buch. Condición: Neu. Druck auf Anfrage Neuware - Printed after ordering - Written by leading world experts, this third edition embraces the philosophy of international collaboration and disseminates the latest advances and transformative changes in the field of thyroid cancer.It provides a global health perspective, striving towards a uniform, equitable, evidence-based, cost-effective, practical, and patient-centred approach with high quality care crossing geographical boundaries. This book covers controversial issues and the most up-to-date management of differentiated, medullary, anaplastic, and rarer types of thyroid cancers together with survivorship issues and the lessons learnt during the Covid-19 Pandemic.The molecular landscape of thyroid cancers has a high frequency of oncogenic driver mutations and a high frequency of gene fusions treatable by new gene-specific systemic therapies. These include dual MAPK (Dabrafenib) / MEK (Trametinib) inhibition in BRAF V 600E mutated Anaplastic Thyroid Cancer, Larotrectinib, Entrectinib for NTRKgene fusion, Selpercartinib, Pralsetinib for RET fusion and mutations. These, newer and Master protocol trials, Tumour Agnostic drug development, Immune Checkpoint blockade and CAR-T therapy etc are discussed.The latest NICE and African Guidelines for Management are included. This would be of interest to readers as well.This book is aimed at thyroidologists of all disciplines, (in training or experts) students, non-specialist clinicians, nursing staff, all the disciplines involved in a multidisciplinary team such as surgeons - Head & Neck or Endocrine and General Surgeons, Oncologists, Endocrinologists, Nuclear Medicine Physicians, Nuclear Medicine Physicists, Radiologists, Pathologists, Specialist Nurses, Geneticists, Clinical Psychologists, Palliative Care Physicians and, in addition to AI in medicine, telemedicine experts, health policy makers, and scientists.

    • Idioma: Inglés

      Editorial: Springer, 2024

      3031386043 / 9783031386046

      • Tapa dura

      Librería: Mispah books, Redhill, SURRE, Reino UnidoMispah books

      Vendedor de 4 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 315,28

      Envío por EUR 29,10 
      Se envía de Reino Unido a Estados Unidos de America

      Cantidad disponible: 1 disponibles

      hardcover. Condición: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

    • Idioma: Inglés

      Editorial: Springer, 2024

      3031386043 / 9783031386046

      • Tapa dura
      • Impresión bajo demanda

      Librería: Brook Bookstore On Demand, Napoli, NA, ItaliaBrook Bookstore On Demand

      Vendedor de 5 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 142,27

      Envío por EUR 11,00 
      Se envía de Italia a Estados Unidos de America

      Cantidad disponible: Más de 20 disponibles

      Condición: new. Questo è un articolo print on demand.

    • Idioma: Inglés

      Editorial: Springer International Publishing, 2024

      3031386043 / 9783031386046

      • Tapa dura
      • Impresión bajo demanda

      Librería: moluna, Greven, Alemaniamoluna

      Vendedor de 5 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 149,85

      Envío por EUR 48,99 
      Se envía de Alemania a Estados Unidos de America

      Cantidad disponible: Más de 20 disponibles

      Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Covid-19 pandemic and thyroid cancer -- lessons learntArtificial intelligence in thyroid cancerGenomics based platform trials, tumour agnostic drugsDr Ujjal Mallick, MBBS&nbspMS&nbspFRCPE (Hon)&nbspFRCP (Hon) FRCR&nbspCons.

    • Idioma: Inglés

      Editorial: Springer International Publishing Nov 2023, 2023

      3031386043 / 9783031386046

      • Tapa dura
      • Impresión bajo demanda

      Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, AlemaniaBuchWeltWeit Ludwig Meier e.K.

      Vendedor de 5 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 181,89

      Envío por EUR 23,00 
      Se envía de Alemania a Estados Unidos de America

      Cantidad disponible: 2 disponibles

      Buch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Written by leading world experts, this third edition embraces the philosophy of international collaboration and disseminates the latest advances and transformative changes in the field of thyroid cancer.It provides a global health perspective, striving towards a uniform, equitable, evidence-based, cost-effective, practical, and patient-centred approach with high quality care crossing geographical boundaries. This book covers controversial issues and the most up-to-date management of differentiated, medullary, anaplastic, and rarer types of thyroid cancers together with survivorship issues and the lessons learnt during the Covid-19 Pandemic.The molecular landscape of thyroid cancers has a high frequency of oncogenic driver mutations and a high frequency of gene fusions treatable by new gene-specific systemic therapies. These include dual MAPK (Dabrafenib) / MEK (Trametinib) inhibition in BRAF V 600E mutated Anaplastic Thyroid Cancer, Larotrectinib, Entrectinib for NTRKgene fusion, Selpercartinib, Pralsetinib for RET fusion and mutations. These, newer and Master protocol trials, Tumour Agnostic drug development, Immune Checkpoint blockade and CAR-T therapy etc are discussed.The latest NICE and African Guidelines for Management are included. This would be of interest to readers as well.This book is aimed at thyroidologists of all disciplines, (in training or experts) students, non-specialist clinicians, nursing staff, all the disciplines involved in a multidisciplinary team such as surgeons - Head & Neck or Endocrine and General Surgeons, Oncologists, Endocrinologists, Nuclear Medicine Physicians, Nuclear Medicine Physicists, Radiologists, Pathologists, Specialist Nurses, Geneticists, Clinical Psychologists, Palliative Care Physicians and, in addition to AI in medicine, telemedicine experts, health policy makers, and scientists. 416 pp. Englisch.

    • Idioma: Inglés

      Editorial: Springer, Palgrave Macmillan Mär 2024, 2024

      3031386043 / 9783031386046

      • Tapa dura
      • Impresión bajo demanda

      Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemaniabuchversandmimpf2000

      Vendedor de 5 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 181,89

      Envío por EUR 60,00 
      Se envía de Alemania a Estados Unidos de America

      Cantidad disponible: 1 disponibles

      Buch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Draws on international experience across many disciplines offering a practical approach to the topicExamines the latest advances in surgical and non-surgical managementDiscusses molecular studies and translational research and how they have transformed the diagnosis and management of thyroid cancerAddresses current challenges and areas of controversy such as low risk thyroid cancer and papillary microcarcinomaSpringer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 416 pp. Englisch.

    • Idioma: Inglés

      Editorial: Springer, 2024

      3031386043 / 9783031386046

      • Tapa dura
      • Impresión bajo demanda

      Librería: Majestic Books, Hounslow, Reino UnidoMajestic Books

      Vendedor de 4 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 257,28

      Envío por EUR 7,57 
      Se envía de Reino Unido a Estados Unidos de America

      Cantidad disponible: 4 disponibles

      Condición: New. Print on Demand.

    • Idioma: Inglés

      Editorial: Springer, 2024

      3031386043 / 9783031386046

      • Tapa dura
      • Impresión bajo demanda

      Librería: Biblios, frankfurt am main, HESSE, AlemaniaBiblios

      Vendedor de 4 estrellas
      Contactar con el vendedor

      Condición: Nuevo

      EUR 261,78

      Envío por EUR 9,95 
      Se envía de Alemania a Estados Unidos de America

      Cantidad disponible: 4 disponibles

      Condición: New. PRINT ON DEMAND.